CD45RB is a novel molecular therapeutic target to inhibit Abeta peptide-induced microglial MAPK activation (Q33334431)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
CD45RB is a novel molecular therapeutic target to inhibit Abeta peptide-induced microglial MAPK activation
scientific article

    Statements

    CD45RB is a novel molecular therapeutic target to inhibit Abeta peptide-induced microglial MAPK activation (English)
    0 references
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit